FIELD: medicine, pharmaceutics.
SUBSTANCE: invention discloses a tablet for treating or preventing viral infections which contains 50-95% of 6-fluor-3-hydroxy-2-pyrazincarboxamide or its salt; it has a size facilitating ingestion; it possesses excellent release characteristics of the active principle and has hardness.
EFFECT: method enables the tablet maintaining stability when applying a film coating, packing and transporting.
16 cl, 19 ex, 4 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| TABLET, WHICH IS DECOMPOSED IN MOUTH | 2008 |
|
RU2478375C2 |
| TABLET CONTAINING 5-HYDROXY-1H-IMIDAZOLE-4-CARBOXAMIDE | 2014 |
|
RU2654703C2 |
| PILL CONTAINING METHANESULFONATE HYDRATE OF 1-CYCLOPROPYL-8-(DIFLUOROMETHOXY)-7-[(1R)-1-METHYL-2,3-DIHYDRO-1H-ISOINDOLE-5-YL]-4-OXO-1,4-DIHYDROQUINOLINE-3-CARBOXYLIC ACID | 2012 |
|
RU2633477C2 |
| SOLID PHARMACEUTICAL COMPOSITION CONTAINING 1-(3-(2-(1-BENZOTHIOPHENE-5-YL)ETOXY)PROPYL)AZETIDINE-3-OL OR ITS SALT | 2013 |
|
RU2625767C2 |
| HYDROMORPHONE HYDROCHLORIDE-CONTAINING ORAL SUSTAINED-RELEASE PHARMACEUTICAL COMPOSITION | 2013 |
|
RU2665372C2 |
| COMPOSITIONS IN FIXED DOSES | 2018 |
|
RU2810163C2 |
| PHARMACEUTICAL COMPOSITIONS CONTAINING S1P RECEPTOR MODULATOR | 2007 |
|
RU2487703C2 |
| CONTROLLED RELEASE SOLID PREPARATION | 2006 |
|
RU2496480C2 |
| PHARMACEUTICAL PREPARATIONS WITH FIXED COMBINATION OF ANALGESIC AND ANTISPASMODIC AGENTS DOSES | 2015 |
|
RU2704613C2 |
| SOLID PREPARATION | 2004 |
|
RU2359661C2 |
